发明名称 THERAPEUTIC AGENT FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
摘要 <p>Disclosed is a method for the prevention and/or treatment of a chronic obstructive pulmonary disease by administrating a 5-membered cyclic compound represented by the formula below or a pharmaceutically acceptable salt of the compound or a prodrug of the compound or salt: wherein X represents an oxygen or sulfur atom; R&lt;SUP&gt;1&lt;/SUP&gt; represents a hydrogen atom, a substituted or unsubstituted alkyl or the like; R&lt;SUP&gt;2&lt;/SUP&gt; represents a hydrogen atom, a substituted or unsubstituted alkyl or the like; Y&lt;SUP&gt;1&lt;/SUP&gt; represents a single bond, a substituted or unsubstituted alkylene or the like; the wavy line means an (E) or (Z) coordination; R&lt;SUP&gt;3&lt;/SUP&gt; represents a hydrogen atom, a substituted or unsubstituted aryl or the like; Y&lt;SUP&gt;2&lt;/SUP&gt; represents a substituted or unsubstituted alkylene or an alkenylene; R&lt;SUP&gt;4&lt;/SUP&gt; represents a hydrogen atom, a substituted or unsubstituted alkanoyl or the like; and R&lt;SUP&gt;5&lt;/SUP&gt; represents a hydrogen atom or a substituted or unsubstituted alkyl.</p>
申请公布号 WO2006118268(A1) 申请公布日期 2006.11.09
申请号 WO2006JP309028 申请日期 2006.04.28
申请人 JP;JP;JP;JP;JP 发明人 SUGASAWA, TOSHINARI;NAKAJIMA, TAKASHI;FUJITA, HITOSHI;KANAI, TOSHIO
分类号 A61K31/5377;A61K31/56;A61K45/00;A61P11/00;C07D277/20;C07D277/42 主分类号 A61K31/5377
代理机构 代理人
主权项
地址